Elan, Eisai To Pay $214M Over Zonegran Marketing

By Jocelyn Allison · December 16, 2010, 1:56 PM EST

The U.S. government has finalized a $203.5 million criminal and civil settlement with Irish drugmaker Elan Corp. PLC over off-label marketing of epilepsy drug Zonegran, as well as revealed an $11...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Recent Articles By Jocelyn

February 22, 2019
Tracing Puerto Rico's Journey Through Bankruptcy
November 09, 2016
After Trump's Triumph, What's Next?
January 21, 2011
United, Merck Hit With Navy Communications IP Suits
January 19, 2011
FDA Unveils Changes To Medical Device Review Process
January 19, 2011
8th Circ. Revives Class Action Over KV Recalls
January 18, 2011
Weil Advises Advent In $1.5B Buy Of Priory From RBS
January 13, 2011
Ex-Home Diagnostics CEO Charged With Insider Trading
January 04, 2011
FDA Tackles Food Safety As Funding Remains Uncertain
December 15, 2010
FDA Warns Of Hidden Ingredients In Supplements
December 14, 2010
Judge OKs $27M Deal In Cooper Securities Action